New Canadian dyslipidemia guidelines now recommend monitoring C-reactive protein in some patients

November 2009

New Canadian dyslipidemia guidelines now recommend monitoring C-reactive protein in some patients.

High sensitivity C-reactive protein (hs-CRP) will be used to determine whether to treat moderate-risk patients who DON'T have high cholesterol.

High-risk patients almost always get statins...and low-risk patients rarely do unless they have very high cholesterol.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Infectious Diseases New Canadian guidelines will change acute otitis media treatment
Influenza questions that people currently have about the new H1N1 flu vaccine
Influenza giving acetaminophen to children before vaccinations might reduce immunity
Influenza Compounding Tamiflu suspension and Relenza is leading to problems
Psychiatry new warnings about strange sleep-related behaviour with all Rx sleep meds
Dyslipidemia New Canadian dyslipidemia guidelines now recommend monitoring C-reactive protein in some patients
Dyslipidemia whether Niaspan FCT has any advantages over the older formulation of Niaspan
Women's Health how to switch women from oral to topical estrogens
Women's Health whether ginger is safe during pregnancy
supplements for colds and flu
Cardiology whether proton pump inhibitors decrease the efficacy of clopidogrel (Plavix)
Obesity & Weight Loss help adjusting meds after bariatric surgery
Diabetes reports of acute pancreatitis with sitagliptin (Januvia, Janumet)